EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The future of healthcare‐associated infection surveillance: Automated surveillance and using the potential of artificial intelligence

Suzanne D van der Werff iD, Stephanie M van Rooden iD, Aron Henriksson iD, Michael Behnke iD, Seven J S Aghdassi iD, Maaike S M van Mourik iD, Pontus Nauclér iD

Journal of Internal Medicine · 2025-08 · 298 (2) · 54-77

DOI: 10.1111/joim.20100 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Internal Medicine, online erschienen am 05.06.2025. Verfasst von Suzanne D van der Werff und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine Solna, Division of Infectious Diseases, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Artificial Intelligence, Cross Infection, Population Surveillance. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Berlin Institute of Health, Vetenskapsrådet, VINNOVA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Healthcare‐associated infections (HAIs) are common adverse events, and surveillance is considered a core component of effective HAI reduction programmes. Recently, efforts have focused on automating the traditional manual surveillance process by utilizing data from electronic health record (EHR) systems. Using EHR data for automated surveillance, algorithms have been developed to identify patients with (ventilator‐associated) pneumonia and (catheter‐related) bloodstream, surgical site, (catheter‐associated) urinary tract and Clostridioides difficile infections (sensitivity 54.2%–100%, specificity 63.5%–100%). Mostly methods based on natural language processing have been applied to extract information from unstructured clinical information. Further developments in artificial intelligence (AI), such as large language models, are expected to support and improve different aspects within the surveillance process; for example, more precise identification of patients with HAI. However, AI‐based methods have been applied less frequently in automated surveillance and more frequently for (early) prediction, particularly for sepsis. Despite heterogeneity in settings, populations, definitions and model designs, AI‐based models have shown promising results, with moderate to very good performance (accuracy 61%–99%) and predicted sepsis within 0–40 h before onset. AI‐based prediction models detecting patients at risk of developing different HAIs should be explored further. The continuous evolution of AI and automation will transform HAI surveillance and prediction, offering more objective and timely infection rates and predictions. The implementation of (AI‐supported) automated surveillance and prediction systems for HAI in daily practice remains scarce. Successful development and implementation of these systems demand meeting requirements related to technical capabilities, governance, practical and regulatory considerations and quality monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceCross InfectionPopulation SurveillanceHumansElectronic Health RecordsAlgorithmsCatheter-Related Infections

Stichwörter der Autor:innen

artificial intelligenceautomated surveillanceearly predictionhealthcare‐associated infectionssepsis

Autor:innen und Institutionen

  • Department of Medicine Solna, Division of Infectious Diseases, Karolinska Institutet, Stockholm, Sweden.
  • Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Epidemiology and Surveillance, Centre for Infectious Disease Epidemiology and Surveillance, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
  • Department of Computer and Systems Sciences, Stockholm University, Stockholm, Sweden.
  • Institute of Hygiene and Environmental Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Berlin Institute of Health, BIH Biomedical Innovation Academy, BIH Charité Digital Clinician Scientist Program, Charité-Universitätsmedizin Berlin, Berlin, Germany.

ORCID-Profile: Suzanne D van der Werff, Stephanie M van Rooden, Aron Henriksson, Michael Behnke, Seven J S Aghdassi, Maaike S M van Mourik, Pontus Nauclér

Förderung

  • Berlin Institute of Health
  • Vetenskapsrådet
  • VINNOVA
  • DFG, the Charité Universitätsmedizin - Berlin
  • Ministerie van Volksgezondheid, Welzijn en Sport
  • Region Stockholm

Zitieren

APA

van der Werff, S. D., van Rooden, S. M., Henriksson, A., Behnke, M., Aghdassi, S. J. S., van Mourik, M. S. M., & Nauclér, P. (2025). The future of healthcare‐associated infection surveillance: Automated surveillance and using the potential of artificial intelligence. Journal of Internal Medicine, 298(2), 54-77. https://doi.org/10.1111/joim.20100

Vancouver

van der Werff SD, van Rooden SM, Henriksson A, Behnke M, Aghdassi SJS, van Mourik MSM, et al. The future of healthcare‐associated infection surveillance: Automated surveillance and using the potential of artificial intelligence. Journal of Internal Medicine. 2025;298(2):54-77. doi:10.1111/joim.20100

BibTeX
@article{vanderWerff2025,
  author = {van der Werff, Suzanne D and van Rooden, Stephanie M and Henriksson, Aron and Behnke, Michael and Aghdassi, Seven J S and van Mourik, Maaike S M and Nauclér, Pontus},
  title = {The future of healthcare‐associated infection surveillance: Automated surveillance and using the potential of artificial intelligence},
  journal = {Journal of Internal Medicine},
  year = {2025},
  volume = {298},
  number = {2},
  pages = {54--77},
  doi = {10.1111/joim.20100}
}
Kostenlos starten →